Literature DB >> 23561715

[A comparison of Airtraq™ laryngoscope and standard direct laryngoscopy in adult patients with immobilized cervical spine].

M Amor1, S Nabil, M Bensghir, A Moussaoui, S Kabbaj, N Drissi Kamili, W Maazouzi.   

Abstract

INTRODUCTION: Airtraq laryngoscope is a new and single use device for endotracheal intubation. Few studies showed the superiority of the Airtraq comparing to Macintosh laryngoscope in the setting of difficult intubation. STUDY
DESIGN: To compare the performance of these two laryngoscopes by simulating a situation of reduced mobility of the cervical spine by applying the Manual in-line stablization (MILS) maneuver. PATIENTS AND METHODS: After obtaining the approval of the ethic committee, we realized a prospective single blind randomized study. During a 6-month period, 120 consenting patients scheduled for ORL or ophthalmologic surgery were included. They all had general anesthesia and orotracheal intubation. These patients were randomly and equally divided in two groups (n=60), depending on the type of the laryngoscope used (Airtraq or Macintosh). Were excluded from the study the patients with history or criteria predicting difficult intubation. Each patient was intubated by one of the five experimented anesthetists selected for this work. The principle judgment criteria were: i) the time taken for the orotracheal intubation and ii) the intubation difficulty score (IDS). The secondary judgment criterion was the hemodynamic modifications after the endotracheal intubation.
RESULTS: Demographic and upper airway track variables were comparable between the two groups. There was no case of failure of intubation in this serie. Nonetheless, all the patients of the Airtaq group were intubated from the first attempt, whereas half of the patients of the Macintosh group were intubated after the third attempt. Comparing to the Macintosh, the Airtraq reduces the time taken for the orotracheal intubation (14±1s vs 19±3s, P=0.01), the necessity of additional maneuver to facilitate the intubation, and the intubation difficulty score (0.7±0.3 vs 3.8±1, P<0.001). Orotracheal intubation using the Airtraq laryngoscope caused less hemodynamic stimulation than using the Macintosh.
CONCLUSION: Our study showed the usefulness of the Airtraq laryngoscope for endotracheal intubation for patients presenting conditions of difficult intubation such as reduced mobility of the cervical spine.
Copyright © 2013 Société française d’anesthésie et de réanimation (Sfar). Published by Elsevier SAS. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23561715     DOI: 10.1016/j.annfar.2013.01.027

Source DB:  PubMed          Journal:  Ann Fr Anesth Reanim        ISSN: 0750-7658


  5 in total

Review 1.  Videolaryngoscopy versus direct laryngoscopy for adults undergoing tracheal intubation.

Authors:  Jan Hansel; Andrew M Rogers; Sharon R Lewis; Tim M Cook; Andrew F Smith
Journal:  Cochrane Database Syst Rev       Date:  2022-04-04

Review 2.  Videolaryngoscopy versus direct laryngoscopy for adult patients requiring tracheal intubation.

Authors:  Sharon R Lewis; Andrew R Butler; Joshua Parker; Tim M Cook; Andrew F Smith
Journal:  Cochrane Database Syst Rev       Date:  2016-11-15

3.  What you need to know about ossification of the posterior longitudinal ligament to optimize cervical spine surgery: A review.

Authors:  Nancy E Epstein
Journal:  Surg Neurol Int       Date:  2014-04-16

Review 4.  Alternative intubation techniques vs Macintosh laryngoscopy in patients with cervical spine immobilization: systematic review and meta-analysis of randomized controlled trials.

Authors:  L Suppan; M R Tramèr; M Niquille; O Grosgurin; C Marti
Journal:  Br J Anaesth       Date:  2015-06-30       Impact factor: 9.166

5.  Split Type Postman videolaryngoscope: The newer device versus the standard Macintosh laryngoscope in simulated difficult airway - A new hope for difficult intubation scenarios.

Authors:  N S Nisanth; Qazi E Ali; Syed H Amir
Journal:  Indian J Anaesth       Date:  2022-03-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.